These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6345465)

  • 21. [Evaluation on the effects of community-based comprehensive prevention and control of hypertension in the rural areas in China].
    Li J; Cao W; Hu Y; Zhan S; Li P; Li X; Wu T; Wang Y; Wang S; Sun Y; Li L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):185-9. PubMed ID: 11860781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who's really hypertensive?--Quality control issues in the assessment of blood pressure for randomized trials.
    Reid CM; Ryan P; Miles H; Willson K; Beilin LJ; Brown MA; Jennings GL; Johnston CI; Macdonald GJ; Marley JE; McNeil JJ; Morgan TO; West MJ; Wing LM
    Blood Press; 2005; 14(3):133-8. PubMed ID: 16036492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Take Control of Your Blood pressure (TCYB) study: study design and methodology.
    Bosworth HB; Olsen MK; Dudley T; Orr M; Neary A; Harrelson M; Adams M; Svetkey LP; Dolor RJ; Oddone EZ
    Contemp Clin Trials; 2007 Jan; 28(1):33-47. PubMed ID: 16996808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the high-risk and mass strategies on hypertension control and stroke mortality in primary health care.
    Lin T; Chen CH; Chou P
    J Hum Hypertens; 2004 Feb; 18(2):97-105. PubMed ID: 14730324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the quality and effects of hypertension control in populations.
    Strasser T
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S1-8. PubMed ID: 8872816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful modules of community hypertension control programs--examples from the German National High Blood Pressure Programme.
    Hense HW
    J Hum Hypertens; 1996 Feb; 10 Suppl 1():S13-6. PubMed ID: 8965280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of arterial hypertension].
    Balaguer Vintró I
    Med Clin (Barc); 1986 Nov; 87(17):714-6. PubMed ID: 3540482
    [No Abstract]   [Full Text] [Related]  

  • 33. [The on-and-off in hypertension history].
    Ménard J
    Rev Prat; 2010 May; 60(5):638-43. PubMed ID: 20564845
    [No Abstract]   [Full Text] [Related]  

  • 34. [Italian experience in the International Prospective Primary Prevention Study in Hypertension (IPPPSH-Italy). Research structure and organizational criteria].
    Zamboni S; Lazzaretto R; Ambroso G; Ambrosio GB
    G Ital Cardiol; 1988 Aug; 18(8):683-8. PubMed ID: 3243419
    [No Abstract]   [Full Text] [Related]  

  • 35. Mobilizing against hypertension.
    Garbus SB; Garbus SB
    Med Times; 1976 Jul; 104(7):104-8. PubMed ID: 933765
    [No Abstract]   [Full Text] [Related]  

  • 36. Historical perspectives on the management of hypertension.
    Moser M
    J Clin Hypertens (Greenwich); 2006 Aug; 8(8 Suppl 2):15-20; quiz 39. PubMed ID: 16894244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension control: historic perspectives--25 years of progress in Canada and around the world.
    Fodor JG
    Can J Public Health; 1994; 85 Suppl 2():S7-8. PubMed ID: 7804954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should mild hypertension be treated? A guide for the perplexed.
    Langford HG
    J Hypertens Suppl; 1986 Dec; 4(5):S533-6. PubMed ID: 3553484
    [No Abstract]   [Full Text] [Related]  

  • 39. Framingham Study insights on the hazards of elevated blood pressure.
    Kannel WB; Wolf PA
    JAMA; 2008 Dec; 300(21):2545-7. PubMed ID: 19050198
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood pressure. 1911.
    McClure JC
    Practitioner; 2011 Oct; 255(1744):32. PubMed ID: 23251990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.